Art Community

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

SHANGHAI, June 23, 2026 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic research collaboration and license agreement with Eli Lilly and Company ("Lilly"), a leading…

Read the full release →

News provided by PR Newswire.

Art Community

Advance ER Urges World Cup Visitors & DFW Residents to Prioritize Sexual Health

June 30, 2026

Art Community

Mental Health Association’s GOFCC Program Celebrates 100 Licensed Family Child Care Educators, Expanding Access for Families Across Western Maryland

June 26, 2026

Art Community

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

June 26, 2026

Art Community

Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium

June 26, 2026